1065 ACTM-838, a microbial-based immunotherapy that enriches in solid tumors after IV dosing, reverses the immunosuppressive TME to promote durable anti-tumor immunity, alone and in combination with anti-PD1 in mice

Autor: Akshata Udyavar, Hailey He, John Brandenburg, Julie Janes, Oanh Pham, Sara Tribble, Ryan Daroy, Keith Cheung, Haixing Kehoe, Bret Peterson, Emily Miyashita-Lin, Omkar Joshi, Nick Eisele, Christopher Thanos, Chan Whiting
Rok vydání: 2022
Zdroj: Regular and Young Investigator Award Abstracts.
Databáze: OpenAIRE